What is Boston Scientific Corp worth?
With the base-case assumptions below, a discounted cash flow model on Boston Scientific Corp's reported free cash flow gives $73.93 per share. The share price was $43.92 on September 25, 2026, 41% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 10.0% | 10.0% | $42.19 | -4% |
| Base | 15.0% | 9.0% | $73.93 | +68% |
| Bull | 20.0% | 8.0% | $133.01 | +203% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $97.95 | $105.44 | $114.60 | $126.04 | $140.76 |
| 8.0% | $79.90 | $84.76 | $90.50 | $97.39 | $105.81 |
| 9.0% | $66.77 | $70.09 | $73.93 | $78.40 | $83.68 |
| 10.0% | $56.81 | $59.18 | $61.85 | $64.91 | $68.44 |
| 11.0% | $49.02 | $50.76 | $52.69 | $54.87 | $57.34 |
Where the presets come from
Base: years 1 to 5 grow at Boston Scientific Corp's revenue growth rate over the last 5 fiscal years (15.2% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions